dshps and dsips CMS to end federal match for states' Medicaid funding requests The End of DSHP &

Healthcare practitioners who compound, prescribe or supply unapproved peptide products have been warned by the Therapeutic Goods Administration (TGA) to comply with regulatory requirements and professional practice standards

It significantly upregulates VEGF (vascular endothelial growth factor) expression, stimulating endothelial cell proliferation and tubule formation

Not for human or animal use, consumption, diagnosis, treatment, food, supplement, cosmetic, veterinary, or similar end use

This peptide is thought to have a dual-switch mechanism: burning existing fat and preventing your body from making new fat